CO6852074A2 - Novedosos derivados de ftalazinona-pirrolopirimidinacarboxamida - Google Patents

Novedosos derivados de ftalazinona-pirrolopirimidinacarboxamida

Info

Publication number
CO6852074A2
CO6852074A2 CO14004200A CO14004200A CO6852074A2 CO 6852074 A2 CO6852074 A2 CO 6852074A2 CO 14004200 A CO14004200 A CO 14004200A CO 14004200 A CO14004200 A CO 14004200A CO 6852074 A2 CO6852074 A2 CO 6852074A2
Authority
CO
Colombia
Prior art keywords
pyrrolopyrimidinecarboxamide
derivatives
novel phthalazinone
phthalazinone
novel
Prior art date
Application number
CO14004200A
Other languages
English (en)
Spanish (es)
Inventor
Thomas Stengel
Thomas Maier
Alexander Mann
Josef Stadlwieser
Dieter Flockerzi
Andreas Pahl
Ewald Benediktus
Manuela Hessmann
Tobias Kanacher
Ragna Hussong
Christof Zitt
Hans Christof Holst
Rolf-Peter Hummel
Martin Viertelhaus
Hermann Tenor
Torsten Dunkern
Armin Hatzelmann
Christian Hesslinger
Original Assignee
Takeda Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=44764312&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CO6852074(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Takeda Gmbh filed Critical Takeda Gmbh
Publication of CO6852074A2 publication Critical patent/CO6852074A2/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CO14004200A 2011-06-17 2014-01-10 Novedosos derivados de ftalazinona-pirrolopirimidinacarboxamida CO6852074A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP11170440 2011-06-17

Publications (1)

Publication Number Publication Date
CO6852074A2 true CO6852074A2 (es) 2014-01-30

Family

ID=44764312

Family Applications (1)

Application Number Title Priority Date Filing Date
CO14004200A CO6852074A2 (es) 2011-06-17 2014-01-10 Novedosos derivados de ftalazinona-pirrolopirimidinacarboxamida

Country Status (22)

Country Link
US (2) US20140112945A1 (https=)
EP (1) EP2721030B1 (https=)
JP (1) JP5980318B2 (https=)
KR (1) KR20140037195A (https=)
CN (1) CN103582644B (https=)
AR (1) AR086915A1 (https=)
AU (1) AU2012269133A1 (https=)
BR (1) BR112013031791A2 (https=)
CA (1) CA2837248A1 (https=)
CL (1) CL2013003556A1 (https=)
CO (1) CO6852074A2 (https=)
CR (1) CR20130656A (https=)
DO (1) DOP2013000298A (https=)
EA (1) EA023713B1 (https=)
EC (1) ECSP13013076A (https=)
ES (1) ES2564882T3 (https=)
MA (1) MA35269B1 (https=)
MX (1) MX2013014888A (https=)
PE (1) PE20140648A1 (https=)
PH (1) PH12013502546A1 (https=)
TN (1) TN2013000439A1 (https=)
WO (1) WO2012171900A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20170133497A (ko) 2015-04-09 2017-12-05 갈데르마 소시에떼아노님 인디고 내추럴리스로부터의 추출물 및 그의 제조 방법
JP6803849B2 (ja) * 2015-04-09 2020-12-23 ガルデルマ・ソシエテ・アノニム インジゴナチュラリス又はインジゴ産生植物の抽出物を用いたアトピー性皮膚炎の処置
BR112017021190B1 (pt) 2015-04-09 2021-12-21 Galderma Sa. Uso de uma composição farmacêutica que compreende um extrato de indigo naturalis
EP3280428A1 (en) 2015-04-09 2018-02-14 Galderma S.A. Antibacterial indigo naturalis or indigo-producing plant extract and use thereof
WO2022006470A1 (en) 2020-07-01 2022-01-06 Vanderbilt University Methods of treatment for a kidney disease

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8828477D0 (en) 1988-12-06 1989-01-05 Riker Laboratories Inc Medical aerosol formulations
ATE111364T1 (de) 1989-05-31 1994-09-15 Fisons Plc Medikament und inhalationsvorrichtung dafür.
GB8921222D0 (en) 1989-09-20 1989-11-08 Riker Laboratories Inc Medicinal aerosol formulations
IL97065A (en) 1990-02-02 1994-01-25 Fisons Plc Repellent preparations for aerosol
DE4003272A1 (de) 1990-02-03 1991-08-08 Boehringer Ingelheim Kg Neue treibgasmischungen und ihre verwendung in arzneimittelzubereitungen
DE69131867T2 (de) 1990-03-23 2000-05-18 Minnesota Mining And Mfg. Co., Saint Paul Anwendung von löslichen fluorhaltigen Tensiden zur Herstellung von Aerosol-Präparaten mit dosierter Abgabe
ATE114112T1 (de) 1990-10-18 1994-12-15 Minnesota Mining & Mfg Aerosolzubereitung, die beclometason 17,21- dipropionat enthält.
AU650953B2 (en) 1991-03-21 1994-07-07 Novartis Ag Inhaler
IL104068A (en) 1991-12-12 1998-10-30 Glaxo Group Ltd Surfactant-free pharmaceutical aerosol formulation comprising 1,1,1,2-tetrafluoroethane or 1,1,1,2,3,3,3-heptafluoro-n- propane as propellant
GB9213874D0 (en) 1992-06-30 1992-08-12 Fisons Plc Process to novel medicament form
GB9306703D0 (en) 1993-03-31 1993-05-26 Fisons Plc Inhalation device
IL111194A (en) 1993-10-08 1998-02-08 Fisons Plc Process for the production of medicament formulations
BR9806752A (pt) * 1997-01-15 2000-03-14 Byk Gulden Lomberg Chem Fab Ftalazinonas.
SI1070056T1 (en) * 1998-03-14 2004-12-31 Altana Pharma Ag Phthalazinone pde iii/iv inhibitors
JP4672143B2 (ja) 1998-08-04 2011-04-20 ヤゴテック アーゲー 医薬用エーロゾル製剤
US6397838B1 (en) 1998-12-23 2002-06-04 Battelle Pulmonary Therapeutics, Inc. Pulmonary aerosol delivery device and method
AU777167B2 (en) 1999-04-23 2004-10-07 Battelle Memorial Institute Directionally controlled EHD aerosol sprayer
IL146034A0 (en) 1999-04-23 2002-07-25 Battelle Memorial Institute High mass transfer electrosprayer
NZ522882A (en) * 2000-06-05 2004-07-30 Altana Pharma Bv Pyridazinone compounds effective as beta-2-adrenoreceptor agonists as well as PDE4-inhibitors
ES2260299T3 (es) 2000-10-09 2006-11-01 3M Innovative Properties Company Formulaciones medicinales en aerosol.
CZ20032491A3 (cs) 2001-02-15 2004-01-14 Altana Pharma Ag Ftalazinonpiperidinové deriváty
EP1385848A2 (en) 2001-04-25 2004-02-04 ALTANA Pharma AG Phtalazinones derivatives useful as pde4/7 inhibitors
BR0313330A (pt) 2002-08-10 2005-06-14 Altana Pharma Ag Piperidina-ftalazonas substituìdas com pirrolidinadiona como inibidores de pde4
EP1556369A1 (en) * 2002-08-10 2005-07-27 ALTANA Pharma AG Pyridazinone-derivatives as pde4 inhibitors
WO2004018449A1 (en) 2002-08-10 2004-03-04 Altana Pharma Ag Piperidine-derivatives as pde4 inhibitors
EP1587512A2 (en) * 2003-01-14 2005-10-26 ALTANA Pharma AG Pde4 inhibitors for the treatment of neoplasms of lymphoid cells
WO2005075457A1 (en) * 2004-02-04 2005-08-18 Altana Pharma Ag Phthalazinone-derivatives as pde4 inhibitors
DE602005005638T2 (de) 2004-02-04 2009-05-14 Nycomed Gmbh 2-(piperidin-4-yl)-4,5-dihydro-2h-pyridazin-3-on-derivate als pde4-inhibitoren
AR070454A1 (es) * 2008-02-27 2010-04-07 Nycomed Gmbh Pirrolopirimidincarboxamidas y composiciones farmaceuticas que las comprenden
AR077898A1 (es) * 2009-08-26 2011-09-28 Nycomed Gmbh Metilpirrolopirimidincarboxamidas

Also Published As

Publication number Publication date
AR086915A1 (es) 2014-01-29
CR20130656A (es) 2014-02-18
EP2721030B1 (en) 2015-12-16
TN2013000439A1 (en) 2015-03-30
JP5980318B2 (ja) 2016-08-31
CA2837248A1 (en) 2012-12-20
JP2014517021A (ja) 2014-07-17
CN103582644B (zh) 2016-07-20
MX2013014888A (es) 2014-02-27
CN103582644A (zh) 2014-02-12
KR20140037195A (ko) 2014-03-26
WO2012171900A1 (en) 2012-12-20
US20140112945A1 (en) 2014-04-24
EA201400001A1 (ru) 2014-05-30
ECSP13013076A (es) 2014-01-31
US20160108049A1 (en) 2016-04-21
MA35269B1 (fr) 2014-07-03
CL2013003556A1 (es) 2014-06-13
ES2564882T3 (es) 2016-03-29
PH12013502546A1 (en) 2014-01-27
AU2012269133A1 (en) 2014-01-30
BR112013031791A2 (pt) 2017-01-31
EA023713B1 (ru) 2016-07-29
EP2721030A1 (en) 2014-04-23
PE20140648A1 (es) 2014-05-30
DOP2013000298A (es) 2014-03-31

Similar Documents

Publication Publication Date Title
NO2025028I1 (no) Evinacumab - forlenget
NL301241I2 (nl) Belantamab mafodotin
NL301233I2 (nl) spesolimab
NO2021053I1 (no) bimekizumab
NL301081I2 (nl) Avelumab
FIC20250006I1 (fi) Flortausipiiri
PT2684880T (pt) Derivado de dispiropirrolidina
CO6890099A2 (es) Nuevos derivados dihidroquinolina-2-ona
DE102011100082A8 (de) Traygreifvorrichtung
EP2752374A4 (en) gooseneck
HUE040412T2 (hu) Fúróimplantátum-sebészethez
IL231950B (en) Aryl-quinoline derivatives
BR112014000879A2 (pt) deflegmador
CO6960557A2 (es) Derivados de 2-yodo-imidazol
PL2762466T3 (pl) Pochodna fenylu
CO6852074A2 (es) Novedosos derivados de ftalazinona-pirrolopirimidinacarboxamida
PT2665720E (pt) Derivados de 2-metoxi-piridin-4-ilo
DK2476953T3 (da) Fluidbedkedel
EP2747907A4 (en) SINKING PANEL OF ORES
EP2694655A4 (en) pAVEC
NO2022008I1 (no) frunevetmab
FIU20114066U0 (fi) Radon-putkitusjärjestely
ES1074469Y (es) Salvacubo
FI9556U1 (fi) Kuorsauksenestokoje
FI9555U1 (fi) Lumentyönnin

Legal Events

Date Code Title Description
FC Application refused